Sodium orthovanadate affects growth of some human epithelial cancer cells (A549, HTB44, DU145)

Folia Biologica

Volumn 56, Issue 3-4, 2008, Pages 115-121

  Klein, Andrzej ^a   Holko, Przemyslaw ^a   Ligeza, Janusz ^a   Kordowiak, Anna M ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Autocrine growth; Human epithelial cancer cells; Orthovanadate (Na 3 VO4 or OV)

Indexed keywords

CRYSTAL VIOLET; GROWTH INHIBITOR; VANADIC ACID;

ANALYSIS OF VARIANCE; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; EPITHELIUM CELL; HUMAN; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; EPITHELIAL CELLS; GENTIAN VIOLET; GROWTH INHIBITORS; HUMANS; VANADATES;

EID: 48249146581     PISSN: 00155497     EISSN: None     Source Type: Journal    
DOI: 10.3409/fb.56_3-4.115-121     Document Type: Article

References (39)

1. ALMEDEIDA M., FILIPE S., HUNANIES S., MALA M. F., MELO R., SEVERINO N., SILVA J. A., FREESTO DA SILVA J. J., WEVER R. 2001. Vanadium haloperoxidases from brown algae of the Laminaridacae family. Phytochemistry 52:633-642.
2. BAN J., MAYSINGER D., KOVAČ V., GALETIĆ I., MATULIĆ M., HADŽIJA M., UŽAREVIĆ B. 2000. Molecular mechanisms involved in the antiproliferative action of protein tyrosine phosphatase inhibitor potassium bisperoxo(1,10-phenanthroline)oxovanadate. Life Sciences 68: 165-175.
3. BERGSTRALH D. T., TING J. P-Y. 2006. Microtubule stabilizing agents: their molecular signaling consequences and potential for enhancement by drug combination. Cancer Treat. Rev. 32: 166-179.
4. CAPELLA L. S., GEFE M. R., SILVA E. F., AFFONSO- MITIDIERI O., LOPES A. G., RUMJANEK V.M., CAPELLA M. A. M. 2002. Mechanisms of vanadate- induced cellular toxicity: role of cellular glutathione and NADPH. Archives Biochem. Biophys. 406: 65-72.
5. CRANS D. C., SMEE J. J., GAIDAMAUSKAS E., YANG L. 2004. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem. Rev. 104: 849-902.
6. DABROS W., GOC A., TURYNA B., KORDOWIAK A. M. 2006. Sodium metavanadate affected control and streptozotocin-diabetic rat liver Golgi complexes. Pol. J. Pathol. 57: 91-97.
7. DABROS W., KAJDA B., KORDOWIAK A. M. 2003. The inhibitory effect of bis(2,2'-bipyridine) oxovanadium(IV) sulphate on the growth of rat hepatoma cell line H35-19, ELSO Proceedings DRESDEN, GERMANY Abstract no. 228, p. 79.
8. DABROS W., KORDOWIAK A. M. 2007. Comparison of bipirydyl, maltol and kojic acid action as organic vanadium ligands on activity of galactosyltransferase (EC 2.4.1.38), some physiological parameters and ultrastructure of Golgi complexes in rat hepatocytes. Folia Histochem. Cytobiol. 45: 239-244.
9. DABROS W., NIKIFORUK A., KORDOWIAK A. M. 2004a. The influence of bis(kojato)-oxovanadium(IV) on viability and proliferation of rat hepatoma cell line H 35-19. ELSO Proceedings NICE, FRANCE Abstract no. 653, p. 299.)
10. DABROS W., NIKIFORUK A., KORDOWIAK A. M. 2004b. Morphology and biochemical activity of rat liver Golgi complexes after pretreatment with bis(kojato)oxoanaium(IV) or kojic acid alone. Pol. J. Pathol. 55: 15-21.
11. DING M., LI J. J., LEONARD S. S., YE J. P., SHI X., COLBURN N. H., CASTRANOVA V., VALLYATHAN V. 1999. Vanadate-induced activation of activator protein 1: Role of reactive oxygen species. Carcinogenesis 20: 663-668.
12. DOMINGO J. L. 2000. Vanadium and diabetes. What about vanadium toxicity. Mol. Cell Biochem. 203: 185-187.
13. DOMINGO J. L. 1996. Vanadium: Review of the reproductive and developmental toxicology. Reprod. Toxicol. 10: 175-182.
14. EVANGELOU A., KARKABOUNAS S., KALPOUZOS G., MALAMAS M., LIASKO R., STEFANOU D., VLAHOS A. T., KABANOS T. A. 1997. Comparison of the therapeutic effects of two vanadium complexes administered at low doses on benzo[a]-pyrene-induced malignant tumors in rats. Cancer Letters 119: 221-225.
15. FRENCH R. J., JONES P. J. H. 1993. Role of vanadium in nutrition: metabolism, essentiality and dietary considerations Life Sci. 52: 339-346.
16. GILLIES R. J., DIDIER N., DENTON M. 1986. Determination of cell number in monolayer cultures. Anal. Biochem. 159: 109-113.
17. GOLDFINE A. B., PATTI M. E., ZUBERI L., GOLDSTEIN B. J., LEBLANC R., LANDAKER E. J., JIANG Z. Y., WILLSKY G. R., KAHN C. R. 2000. Metabolic effects of vanadyl sulphate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism 49: 400-410.
18. 4) on autocrine growth of human epithelial cancer cell lines. Pol. J. Pathol. 59: 3-8.
19. IVANCSITS S., PILGER A., DIEM E., SCHAFFER A., RÜDIGER H. W. 2002. Vanadate induces DNA strand breaks in cultured human fibroblast at doses relevant to occupational exposure. Mutation Research 519: 25-35.
20. KAWABE K., YOSHIKAWA Y., ADACHI Y., SAKURAI H. 2006. Possible mode of action for insulinmimetic activity of vanadyl(IV) compounds in adipocytes. Life Sci. 78:2860-2866.
21. KORDOWIAK A. M., DABROS W., KAJDA B. 2002. Influence of a new vanadium complex, bis(2,2'-bipirydine)oxovanadium(IV) sulfate on liver Golgi complexes from control and streptozotocin-diabetic rats. Hormone Metab. Res. 34: 1-5.
22. KORDOWIAK A. M., DZIGA D., DABROS W. 2004. Streptozotocin-induced alterations of rat liver Golgi complexes are ameliorated by BMOV [bis(maltolato)oxovanadium(IV)] activity Horm. Metab. Res. 36: 148-154.
23. 3 on proliferation, viability and morphology of H35-19 rat hepatoma cell line. Pol. J. Pathol. 58: 51-57.
24. 4) on proliferation and survival of epithelial cancer cells (A549, DU145, HTB44). The 15th Intern. Symp. Polish Network of Molecular and Cellular Biology UNESCO/PAS. Abstracts, pp. 328-330.
25. MOLINUEVO M. S., BARRIO D. A., CORTIZO A. M., ETCHEVERRY S. B. 2004. Antitumoral properties of two new vanadyl(IV) complexes in culture: role of apoptosis and oxidative stress. Cancer Chemother. Pharmacol. 53: 163-172.
26. MOSMANN T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
27. MOTULSKY H. 1996. Analyzing data with GraphPad Prism. San Diego SA, Graph Pad Software Inc.
28. MUKHERJEE B., PATRA B., MAHAPATRA S., BANARJEE P., AMIT T., CHATTERJEE M. 2004. Vanadium-an element of atypical biological significance. Toxicol. Lett. 150: 135-143
29. RODRÍGUEZ-MERCADO J. J., ROLDÁN- REYES E., ALTAMI-RANO-LOZANO M. 2003 Genotoxic effects of vanadium (IV) in human peripheral blood cells. Toxicol. Lett. 144: 359-369.
30. SAKAI A. 1997. Orthovanadate, an inhibitor of protein tyrosine phosphatases acts more potently as a promoter than an inhibitor in the BALB/3T3 cell transformation. Carcinogenesis 18: 1395-1397.
31. SCRIVENS P. J., ALAOUI-JAMALI M. A., GIANNINI G., WANG T., LOIGNON M., BATIST G., SANDOR V. A. 2003. Cdc25A-inhibitory properties and antineoplastic activity of bisperoxyvanadium analogues. Mol. Cancer Ther. 2: 1053-1059.
32. SHI X., HUDSON L. G., LIU K. J. 2004. Oxidative stress and apoptosis in metal ion-induced carcinogenesis. Free Radical Biol. Med. 37: 582-593.
33. STATSOFT STATISTICAL manuals: http://www.statsoft.com
34. THOMPSON K. H., ORVIG C. 2006. Vanadium in diabetes: 100 years from phase 0 to phase I. J. Inorg. Biochem. 100: 1925-1935.
35. VINALS F., MCKENZIE F. R., POUYSSEGUR J. 2001. Growth factor - stimulated protein synthesis is inhibited by sodium orthovanadate. Eur. J. Biochem. 268: 2308-2314.
36. WOZNIAK K., BLASIAK J. 2004. Vanadyl sulphate can differentially damage DNA in human lymphocytes and HeLa Wells. Arch. Toxicol. 78: 7-15.
37. ZHANG Z., HUANG C., LI J., LEONARD S. S., LANCIOTTI R., BUTTERWORTH L., SHI X. 2001. Vanadate-induced cell growth regulation and the role of reactive oxygen species. Arch. Biochem. Biophys. 392: 311-320.
38. ZHANG Z., HUANG C., LI J., SHI X. 2002. Vanadate-induced cell growth arrest is p53-dependent through activation of p21 in C141 cells. J. Inorg. Biochem. 89: 142-148.
39. ZHANG Z., LEONARD S. S, HUANG C., VALLYATHAN V., COSTRANOWA V. 2003. Role of oxygen species and MAPKs in vanadate- induced G2/M phase arrest. Free Radical Bio. Med. 34: 1333-1342.